Moriyama et al. reported on metabolites in two different cell lines for acute lymphoblastic leukemia (Nalm6 and REH) expressing either wild type or a hyperactive mutant (R238W) of cN-II [23]. This evidence concerns the gene NT5C2 and acute lymphoblastic leukemia.